We explored patient pathways for the diagnosis, management and monitoring of idiopathic pulmonary fibrosis (IPF). This was based on NICE published pathways, and interviews with healthcare staff from 14 hospital trusts across England. Data were used in our in-house tool to estimate the cost of each pathway, which were compared to the tariff reimbursement. We found large variation across England in how services for IPF patients are delivered, and variation compared to the NICE pathway.
Hill C, Nasr R, Fisher MI, et. al. Estimated cost and payment by results (PBR) tariff reimbursement for idiopathic pulmonary fibrosis services across 14 specialist providers in England. British Thoracic Society Winter Meeting, London UK. 5th December 2014 MRC-2731